Xylem Inc. (NYSE:XYL) Shares Purchased by Forsta AP Fonden

Key Points

• Forsta AP Fonden increased its stake in Xylem Inc. by 87.0% in the first quarter, owning 106,400 shares valued at approximately $12.7 million.
• Xylem reported quarterly earnings of $1.26 EPS, exceeding estimates and showing a 6.1% increase in year-over-year revenue.
• Analysts currently have an average rating of "Moderate Buy" for Xylem, with a consensus target price of $151.57.

Forsta AP Fonden increased its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 87.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 106,400 shares of the industrial products company's stock after acquiring an additional 49,500 shares during the period. Forsta AP Fonden's holdings in Xylem were worth $12,711,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Dynamic Advisor Solutions LLC purchased a new stake in Xylem during the first quarter worth $694,000. Farther Finance Advisors LLC boosted its position in Xylem by 30.4% during the first quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock worth $215,000 after purchasing an additional 419 shares in the last quarter. NBC Securities Inc. purchased a new stake in Xylem during the first quarter worth $72,000. GAMMA Investing LLC boosted its position in Xylem by 29.1% during the first quarter. GAMMA Investing LLC now owns 4,241 shares of the industrial products company's stock worth $507,000 after purchasing an additional 956 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. boosted its position in Xylem by 19.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 27,215 shares of the industrial products company's stock worth $3,251,000 after purchasing an additional 4,429 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Stock Performance

Shares of NYSE:XYL opened at $142.71 on Friday. The firm has a market capitalization of $34.74 billion, a PE ratio of 37.07, a P/E/G ratio of 2.49 and a beta of 1.11. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The business has a 50-day moving average of $131.23 and a two-hundred day moving average of $125.12. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $145.33.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%. The firm's revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.09 earnings per share. As a group, research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 26th. Stockholders of record on Thursday, May 29th were paid a $0.40 dividend. The ex-dividend date was Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem's dividend payout ratio (DPR) is 41.56%.

Analysts Set New Price Targets

XYL has been the topic of several recent research reports. Raymond James Financial upgraded Xylem to a "hold" rating in a research report on Thursday, May 15th. Stifel Nicolaus upped their price objective on Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research report on Friday, August 1st. JPMorgan Chase & Co. started coverage on Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 target price on the stock. Robert W. Baird lowered their price target on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Finally, UBS Group increased their price objective on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a report on Tuesday. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $151.57.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.